Veteran investor and operating executive focused on growth-stage companies, corporate governance and value-creation strategies for institutional and family-office portfolios. Patricia Frisch brings cross-border M&A and board experience, advising on capital allocation, strategic partnerships and operational scaling. Frequently engages with private equity sponsors and corporate boards to drive EBITDA expansion, commercial go-to-market initiatives and disciplined exit planning.
Veteran investor and operating executive focused on growth-stage companies, corporate governance and value-creation strategies for institutional and family-office portfolios. Patricia Frisch brings cross-border M&A and board experience, advising on capital allocation, strategic partnerships and operational scaling. Frequently engages with private equity sponsors and corporate boards to drive EBITDA expansion, commercial go-to-market initiatives and disciplined exit planning.
Structured, value-oriented growth investor prioritizing scalable business models and governance-driven value creation. Focuses on growth-stage opportunities where operational improvements, strategic partnerships and disciplined capital allocation can expand EBITDA and exit value. Applies cross-border M&A and board-level experience to underwrite go-to-market expansion, operational scaling and sponsor alignment. Prefers sector-agnostic but commercial and software-enabled businesses with clear unit economics, measurable KPIs, and a 3–7 year horizon governed by active oversight and defined exit pathways.
Structured, value-oriented growth investor prioritizing scalable business models and governance-driven value creation. Focuses on growth-stage opportunities where operational improvements, strategic partnerships and disciplined capital allocation can expand EBITDA and exit value. Applies cross-border M&A and board-level experience to underwrite go-to-market expansion, operational scaling and sponsor alignment. Prefers sector-agnostic but commercial and software-enabled businesses with clear unit economics, measurable KPIs, and a 3–7 year horizon governed by active oversight and defined exit pathways.
| Trades 841 | Longs Won 570/841 67% | Profit Factor 6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $372,437.58 |
| Average Win $111,062.29 | Best Trade (Aug 14) $5.01M | Sharpe Ratio -498.85 |
| Average Loss -$38,907.27 | Worst Trade (Aug 28) -$925,687.12 | Z-Score 4.44 (100%) |
| Commissions $0 | Avg. Trade Length 10m 1w | Expectancy $62,425.92 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,042 | 6,338 | 5,634 | 4,930 | 4,225 | 3,521 | 2,817 | 2,113 | 1,408 | 704 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAMI Acadian Asset Management Inc. | 8,157 | $295,316.48 | $751,993.83 | - | $456,677.35 | 154.64% | +0.699% |
AAPL Apple Inc. | 37,933 | $9.5M | $11.47M | - | $1.97M | 20.7% | -0.872% |
ABT Abbott Laboratories | 35,162 | $3.97M | $3.9M | - | -$69,170.94 | -1.74% | +1.085% |
ADEA Adeia Inc. | 10,534 | $346,885 | $296,110.74 | - | -$50,774.26 | -14.64% | +1.407% |
ADP Automatic Data Processing Inc. | 8,814 | $2.57M | $2.37M | - | -$197,023.86 | -7.66% | -0.649% |
AEIS Advanced Energy Industries Inc. | 1,339 | $280,346.78 | $451,671.48 | - | $171,324.7 | 61.11% | +2.97% |
AGX Argan Inc. | 485 | $387,297 | $277,468.5 | - | -$109,828.5 | -28.36% | -1.108% |
AHR American Healthcare REIT, Inc. | 5,483 | $258,323.47 | $288,350.97 | - | $30,027.5 | 11.62% | -0.19% |
AMGN Amgen Inc. | 2,904 | $759,495.05 | $1.21M | - | $449,091.67 | 59.13% | +0.454% |
AMT American Tower Corporation | 5,306 | $973,173.6 | $904,301.58 | - | -$68,872.02 | -7.08% | +0.519% |
AMZN Amazon.com Inc | 16,581 | $3.63M | $4.43M | - | $797,105.68 | 21.93% | -1.833% |
APD Air Products and Chemicals, Inc. | 1,825 | $529,332.12 | $554,927.76 | - | $25,595.64 | 4.84% | -1.694% |
ARW Arrow Electronics Inc. | 1,634 | $348,712 | $343,630.2 | - | -$5,081.8 | -1.46% | +1.855% |
ASML ASML Holding N.V. New York Registry Shares | 979 | $787,677.78 | $1.77M | - | $984,380.65 | 124.97% | +0.594% |
AVGO Broadcom Inc. | 3,532 | $898,487.78 | $1.47M | - | $571,000.82 | 63.55% | -0.007% |
BA Boeing Company | 2,668 | $475,041.16 | $616,841.6 | - | $141,800.44 | 29.85% | -0.875% |
BAC Bank of America Corporation | 32,058 | $1.41M | $2.08M | - | $663,869.66 | 46.96% | +1.266% |
BBIO BridgeBio Pharma, Inc. | 2,838 | $210,749.48 | $237,937.92 | - | $27,188.44 | 12.9% | +0.167% |
BRK-B Berkshire Hathaway Inc. | 13,625 | $6.19M | $6.95M | - | $756,177.65 | 12.21% | -1.251% |
BX Blackstone Inc. | 10,550 | $1.77M | $1.54M | - | -$227,874.22 | -12.86% | -0.516% |